Cargando…
Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration
PURPOSE: To report the reasons for treatment discontinuation within 5 years in patients receiving intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD). METHODS: A retrospective case-notes review of patients commenced on anti...
Autores principales: | Dhingra, Narendra, Upasani, Deepa, Ghanchi, Faruque D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359266/ https://www.ncbi.nlm.nih.gov/pubmed/35647983 http://dx.doi.org/10.4103/ijo.IJO_3066_21 |
Ejemplares similares
-
Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
por: Upasani, Deepa, et al.
Publicado: (2021) -
Choriocapillaris Flow Deficits and Treatment-Naïve Macular Neovascularization Secondary to Age-Related Macular Degeneration
por: Scharf, Jackson M., et al.
Publicado: (2020) -
The Carnitine Shuttle Pathway is Altered in Patients With Neovascular Age-Related Macular Degeneration
por: Mitchell, Sabrina L., et al.
Publicado: (2018) -
Imaging Histology Correlations of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration
por: Berlin, Andreas, et al.
Publicado: (2023) -
Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020)